Sunday, December 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

B of A Securities Analyst Initiates Coverage on Merit Medical Systems with Neutral Rating and 87 Price Target

Elaine Mendonca by Elaine Mendonca
February 7, 2024
in Breaking News
0
Navigating Legal Battles: A Deep Dive into High-Stakes Cryptocurrency Disputes
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On February 7, 2024, Craig Bijou, an analyst at B of A Securities, has started covering Merit Medical Systems (NASDAQ:MMSI) and has given it a Neutral rating. He has also revealed a Price Target of $87 for the stock. This signifies that the analyst holds a balanced viewpoint, neither too optimistic nor pessimistic, regarding the stock’s future performance. The $87 Price Target serves as a benchmark, indicating the analyst’s belief that the stock is fairly valued at this level. This valuable information offers valuable insights to investors and market participants who are closely monitoring Merit Medical Systems’ stock.

MMSI Stock Shows Steady Performance and Potential for Growth in 2024

On February 7, 2024, MMSI stock showed a steady performance, trading in the middle of its 52-week range and above its 200-day simple moving average. The stock closed at $78.62, representing a slight increase of $0.26 or 0.33% since the market last closed.

MMSI’s position in the middle of its 52-week range suggests stability and consistency in its performance.

Trading above its 200-day moving average indicates a long-term upward trend for MMSI.

The modest price increase on February 7, 2024, shows positive movement in the stock’s value.

The lack of significant price changes in after-hours trading suggests no major news or events impacting the stock’s performance.

Overall, MMSI stock demonstrated stability, potential for growth, and may be an attractive option for investors.

Stable Performance and Impressive Financial Results: MMSI Stock Analysis for February 7, 2024

MMSI stock demonstrated a stable performance on February 7, 2024, reflecting the company’s consistent revenue growth and increasing net income. MMSI’s total revenue for the past year amounted to $1.15 billion, showing a 6.21% increase compared to the previous year. The company’s net income also witnessed significant growth over the past year, with a net income of $74.52 million, reflecting a remarkable 53.79% increase compared to the previous year. MMSI’s EPS for the past year stood at $1.29, indicating a substantial increase of 52.95% compared to the previous year. Overall, MMSI’s stock performance on February 7, 2024, was positive, reflecting the company’s impressive financial results. Investors and analysts are likely to view MMSI as a promising investment opportunity, considering its consistent revenue growth, increasing net income, and rising earnings per share. However, further research and analysis are recommended before making any investment decisions.

Tags: MMSI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Investing

Jefferies Analyst Initiates Coverage on ZoomInfo Technologies with a Buy Rating and 20 Price Target

Finance_Investment (5)

Financial Analysts Express Optimism for Civitas Resources Stock Performance

Energy Company Markets and money

RBio Energy Corporations Transformative Journey Becoming a Publicly Traded Company

Recommended

JD.com Stock

Pivotal Week Ahead for JD.com as Major European Acquisition and EV Launch Converge

2 months ago
Snowflake Stock

Snowflake Faces Investor Confidence Test After Executive’s Rogue Forecast

2 months ago
Fiserv Stock

Fiserv’s Strategic Expansion Meets Legal Scrutiny

3 months ago
Does_Walmart_Take_Google_Pay

Does Walmart Take Google Pay? Exploring Walmart’s Exclusive Payment Solution

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

Strategy Inc. Faces a Critical Index Classification Decision

DeFi Technologies Broadens Global Reach with New Listings and Products

Barrick Gold Secures Key Resolution in Mali, Paving Way for Mine Restart

Analyst Upgrade Sends Red Cat Shares Soaring

A Billion-Dollar Vote of Confidence for Standard Lithium

Trending

Tesla Stock
Automotive & E-Mobility

Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push

by Dieter Jaworski
December 21, 2025
0

Tesla shares are trading near their 52-week high as the company approaches a pivotal week, fueled by...

Wolfspeed Stock

Wolfspeed Secures Financial and Strategic Milestones

December 21, 2025
Textron Stock

Textron Stock Approaches Annual Peak Amid Strategic Wins

December 21, 2025
Intellia Therapeutics Stock

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

December 21, 2025
Strategy Stock

Strategy Inc. Faces a Critical Index Classification Decision

December 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push
  • Wolfspeed Secures Financial and Strategic Milestones
  • Textron Stock Approaches Annual Peak Amid Strategic Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com